1. Home
  2. DUOT vs NTHI Comparison

DUOT vs NTHI Comparison

Compare DUOT & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DUOT
  • NTHI
  • Stock Information
  • Founded
  • DUOT 1990
  • NTHI 2008
  • Country
  • DUOT United States
  • NTHI United States
  • Employees
  • DUOT N/A
  • NTHI N/A
  • Industry
  • DUOT Computer Software: Prepackaged Software
  • NTHI Biotechnology: Pharmaceutical Preparations
  • Sector
  • DUOT Technology
  • NTHI Health Care
  • Exchange
  • DUOT Nasdaq
  • NTHI Nasdaq
  • Market Cap
  • DUOT 180.9M
  • NTHI 195.5M
  • IPO Year
  • DUOT N/A
  • NTHI N/A
  • Fundamental
  • Price
  • DUOT $9.87
  • NTHI $8.82
  • Analyst Decision
  • DUOT Strong Buy
  • NTHI
  • Analyst Count
  • DUOT 2
  • NTHI 0
  • Target Price
  • DUOT $12.75
  • NTHI N/A
  • AVG Volume (30 Days)
  • DUOT 340.7K
  • NTHI 74.8K
  • Earning Date
  • DUOT 11-12-2025
  • NTHI 11-14-2025
  • Dividend Yield
  • DUOT N/A
  • NTHI N/A
  • EPS Growth
  • DUOT N/A
  • NTHI N/A
  • EPS
  • DUOT N/A
  • NTHI N/A
  • Revenue
  • DUOT $19,026,308.00
  • NTHI $59,990.00
  • Revenue This Year
  • DUOT $292.26
  • NTHI N/A
  • Revenue Next Year
  • DUOT $43.21
  • NTHI N/A
  • P/E Ratio
  • DUOT N/A
  • NTHI N/A
  • Revenue Growth
  • DUOT 159.00
  • NTHI N/A
  • 52 Week Low
  • DUOT $3.84
  • NTHI $3.20
  • 52 Week High
  • DUOT $11.23
  • NTHI $25.00
  • Technical
  • Relative Strength Index (RSI)
  • DUOT 57.43
  • NTHI 48.81
  • Support Level
  • DUOT $8.10
  • NTHI $5.58
  • Resistance Level
  • DUOT $9.53
  • NTHI $9.45
  • Average True Range (ATR)
  • DUOT 0.79
  • NTHI 1.28
  • MACD
  • DUOT -0.01
  • NTHI -0.09
  • Stochastic Oscillator
  • DUOT 68.94
  • NTHI 47.82

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains that are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).

Share on Social Networks: